---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-239535"
form_type: "8-K"
ticker: "VKTX"
cik: "0001607678"
company_name: "Viking Therapeutics, Inc."
filed_at: "2026-05-26T20:48:01+00:00"
generated_at: "2026-05-26T20:52:26.036947+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Viking Therapeutics annual meeting elects two Class II directors, ratifies auditor

## Summary
- J. Matthew Singleton elected with 28.6M votes for; S. Kathryn Rouan with 22.0M for.
- Ratification of CBIZ CPAs as independent auditor for FY 2026 approved (78.4M for, 1.2M against).
- Advisory vote on named executive officer compensation passed (30.0M for, 12.8M against).
- Quorum achieved with 80.1M shares (69.1% of outstanding) represented at the meeting.

## SEC filing metadata
- accession: 0001193125-26-239535
- form_type: 8-K
- ticker: VKTX
- cik: 0001607678
- company_name: Viking Therapeutics, Inc.
- filed_at: 2026-05-26T20:48:01+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1607678/000119312526239535/0001193125-26-239535-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1607678/000119312526239535/vktx-20260519.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-239535
- JSON: https://secwatch.observer/filing/0001193125-26-239535.json
- Plain text: https://secwatch.observer/filing/0001193125-26-239535.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.